News

Press Release | Sep 27, 2017

Onkos Surgical, Inc., a specialty medtech company dedicated to advancing innovation for the surgical oncology market announced today that it will launch a new service platform focused on preoperative surgical planning called Precision Oncology. The company will showcase the new platform at the upcoming Musculoskeletal Tumor Society (MSTS) held in Denver, Colorado.

Press Release | Sep 19, 2017

Colorescience®, the leading dermatologist-recommended skin health cosmetics company, has earned a Fall Beauty O-Ward for their new All Calm™ Clinical Redness Corrector SPF 50, launched in August 2017. A first-and-only product created to instantly neutralize redness and soothe sensitive skin, it was created to offer immediate color correction, chemical-free SPF 50 UVA/UVB sun protection, and

Press Release | Sep 06, 2017

Nutrition 21, LLC is pleased to announce its expanded partnership with American Media, Inc. (AMI) that is dedicated to educating consumers on the benefits of Nitrosigine. Nitrosigine is scientifically engineered to significantly boost nitric oxide levels, a key factor in increasing blood flow to working muscles^ and is formulated to help consumers train longer, harder

Press Release | Aug 23, 2017

Colorescience®, the leading dermatologist-recommended skin health cosmetics company, is proud to introduce the innovative All Calm™ Clinical Redness Corrector. Formulated for redness, rosacea and sensitive skin, this first-of-its-kind formula instantly calms and soothes skin while its subtle green undertones neutralize redness, and its patent-pending BioSolaceTM complex helps provide ongoing relief from sensitivity and the appearance

News | Aug 04, 2017

Adele is bringing the firm she co-founded, 1315 Capital, L.P., into the newest round for the cosmetics company that Mary spun off from SkinMedica. Colorescience raised $15-million in Series C financing in a round led by 1315.

Press Release | Aug 01, 2017

Colorescience®, the leading dermatologist-recommended skin health cosmetics company, today announced the successful completion of a $15 Million Series C Preferred Stock financing led by 1315 Capital, L.P., a Philadelphia-based healthcare investment firm that specializes in providing expansion and growth capital to specialty pharmaceutical, medical technology, and healthcare services companies.

Press Release | Jul 10, 2017

Nutrition 21’s patented ingredient combining amylopectin and chromium, brand named Velositol, has attained GRAS (generally recognized as safe) status after an extensive and rigorous review of the scientific dossier and safety data conducted by Intertek Health Sciences, Inc.

Press Release | Jun 28, 2017

Bionano Genomics and Genoptix today announced an exclusive agreement to codevelop diagnostic assays for selected hematologic oncology indications. Bionano will contribute its knowledge of genome structure analysis and its Saphyr system, which is designed to accurately visualize the structure of a genome with a simple DNA sample, isolated directly from cancer cells. The platform can

Pages 1 2 3 4